Infect. Immun. doi:10.1128/IAI.00982-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
Use of a Genetically Engineered Strain to Evaluate the Pathogenic Potential of Yeast and Filamentous Forms during Candida albicans Systemic Infection in Immunodeficient Mice
Stephen P. Saville,
Anna L. Lazzell,
Ashok K. Chaturvedi,
Carlos Monteagudo,
and
Jose L. Lopez-Ribot*
Dept. of Biology, The University of Texas at San Antonio, San Antonio, Texas and Departmento de Patología, Universidad de Valencia, Facultad de Medicina y Odontología, Valencia, Spain
* To whom correspondence should be addressed. Email:
jose.lopezribot{at}utsa.edu.
 |
Abstract |
|---|
The pathogenesis of C. albicans systemic infection is complex and results from the balance between its intrinsic virulence attributes and the host immune responses. Morphogenetic transitions between yeast and filamentous forms are considered one of the main virulence attributes in C. albicans. We have examined the pathogenesis of a genetically engineered C. albicans strain, in which morphogenetic conversions can be externally manipulated, in immunodeficient mice; these included B-cell deficient, nude (T-cell-deficient), SCID (lacking both functional T and B cells), and DBA/2N (C5 deficient with impaired neutrophil activity) mice. We also tested mice severely immunosuppressed by cyclophosphamide/cortisone acetate treatment. Mice with specific immune defects were able to survive an infection by yeast cells, but not filamentous forms. However, yeast cells displayed a pathogenic effect leading to lethality in the severely the immunosuppressed mice.